Vistin Pharma ASA: New CEO appointed
25 10월 2023 - 2:45PM
Vistin Pharma ASA: New CEO appointed
Oslo, Norway, 25th of October 2023
The Board of Directors of Vistin Pharma ASA has appointed Magnus
Tolleshaug as the new CEO of Vistin Pharma from 1st of January
2024. Magnus Tolleshaug is currently the CCO in Vistin Pharma, and
will replace the current CEO, Kjell-Erik Nordby. Kjell-Erik has
been the CEO of Vistin Pharma since the company was established in
2015 and has decided to retire. Magnus started his career in Vistin
1st of March 2020 and has been instrumental in delivering Vistin’s
ambitious growth strategy. Before Magnus joined Vistin, he worked
for many years in Takeda Pharmaceuticals as «Head of Global Launch
Excellence & Product Lifecycle Management». Magnus has more
than 20 years of experience from the global pharmaceutical industry
and various international leadership roles.
During Kjell-Erik’s leadership Vistin’s Metformin business has
seen more than 300% revenue growth and he has been essential in
transforming Vistin into a well-recognized world leading Metformin
producer.
*****
For further information, please contact:
Alexander KarlsenCFO+47 97 05 36
21alexander.karlsen@vistin.com
This information is subject to the disclosure requirements
pursuant to section 5-12 of the Norwegian Securities Trading
Act.
Vistin Pharma Asa (LSE:0RAM)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Vistin Pharma Asa (LSE:0RAM)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
